Novogen is developing new

patient-focused

therapies for cancer that have the potential to make a significant impact

Novogen is a global biotechnology company dedicated to creating sustainable long-term shareholder value through the discovery and development of significant new therapies for patients with cancer.

  • News

    ..

    More News

  • Upcoming Events

    23-24 March 2017

    Hong Kong Biotech Invest

    KPMG Hong Kong Central, Hong Kong

    30 March 2017

    Broker meets Biotech, Perth

    Parmelia Hilton, 14 Mill Street, Perth

    11 April 2017

    Proactive Investors Spotlight CEO sessions

    CQ Functions, 113 Queen Street, Melbourne

    More Events

  • In-licensing of GDC-0084

    31-OCT-2016

    Edison research – Novogen Acquires Mid-Stage Cancer Drug from GenentechRead more

    31-OCT-2016

    In-licensing of GDC-0084Read more

    31-OCT-2016

    In-licensing of GDC-0084 – Investor PresentationRead more

  • Share Price

    Historical Prices

SITE BY SPATIAL DESIGN